CARERATING CARERATING NSE
Company Profile ↓Company Overview
CARERATING (CARERATING) is a publicly traded company listed on NSE with a market capitalization of ₹5,043.99 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 18.4%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 18.6%.
Maintains a net profit margin of 36.2%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹473.07 Cr (+17.6% YoY); net profit ₹171.18 Cr.
- Trailing 12 Months Year-on-year growth — revenue +17.6%, earnings +24.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 6.1%, profit CAGR 2.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 6.13% |
| 1 Year: | 17.59% |
Compounded Profit Growth
| 5 Years: | 2.18% |
| 1 Year: | 24.73% |
Stock Price Performance
| 1 Year: | -5.42% |
| 6 Months: | +2.43% |
| 3 Months: | +7.71% |
| 1 Month: | +2.51% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)55.13 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 36.2%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 78.00 Cr | 66.00 Cr | 96.00 Cr | 79.00 Cr | 90.00 Cr | 79.00 Cr | 117.00 Cr | 96.00 Cr | 109.65 Cr | 93.91 Cr | 136.37 Cr | 112.12 Cr | 130.67 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 47.12 Cr | 53.70 Cr | 53.28 Cr | 54.37 Cr | 52.57 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 62.53 Cr | 40.20 Cr | 83.09 Cr | 57.76 Cr | 78.10 Cr |
| Operating Expenses | 50.00 Cr | 49.00 Cr | 55.00 Cr | 55.00 Cr | 61.00 Cr | 57.00 Cr | 62.00 Cr | 66.00 Cr | 18.23 Cr | 15.86 Cr | 18.14 Cr | 21.11 Cr | 21.18 Cr |
| Operating Income | 24.00 Cr | 15.00 Cr | 39.00 Cr | 20.00 Cr | 26.00 Cr | 19.00 Cr | 53.00 Cr | 27.00 Cr | 44.31 Cr | 24.34 Cr | 64.95 Cr | 36.65 Cr | 56.93 Cr |
| EBITDA | 27.00 Cr | 18.00 Cr | 42.00 Cr | 23.00 Cr | 29.00 Cr | 22.00 Cr | 56.00 Cr | 30.00 Cr | 62.54 Cr | 41.43 Cr | 80.99 Cr | 53.33 Cr | 76.46 Cr |
| Interest Expense | 1.00 Cr | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 Cr | 59.64 L | 59.94 L | 61.44 L | 64.70 L | 62.54 L |
| Pretax Income | 34.00 Cr | 26.00 Cr | 50.00 Cr | 34.00 Cr | 36.00 Cr | 30.00 Cr | 64.00 Cr | 39.00 Cr | 58.89 Cr | 37.44 Cr | 76.91 Cr | 48.99 Cr | 72.01 Cr |
| Tax Provision | 13.94 Cr | 8.06 Cr | 14.50 Cr | 10.20 Cr | 11.52 Cr | 9.00 Cr | 17.28 Cr | 10.53 Cr | 15.51 Cr | 10.94 Cr | 19.70 Cr | 12.45 Cr | 18.56 Cr |
| Net Income | 20.00 Cr | 18.00 Cr | 36.00 Cr | 24.00 Cr | 25.00 Cr | 21.00 Cr | 47.00 Cr | 28.00 Cr | 42.61 Cr | 25.78 Cr | 56.67 Cr | 35.90 Cr | 52.83 Cr |
| Diluted EPS | 6.60 | 5.99 | 11.81 | 7.88 | 8.07 | 6.94 | 15.41 | 9.29 | 14.17 | 8.56 | 18.81 | 11.91 | 17.51 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 261.00 Cr | 279.00 Cr | 287.00 Cr | 333.00 Cr | 319.00 Cr | 244.00 Cr | 248.00 Cr | - | 278.99 Cr | 331.68 Cr | 402.32 Cr | 473.07 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 124.11 Cr | 149.98 Cr | 173.76 Cr | 197.92 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 154.88 Cr | 181.71 Cr | 228.56 Cr | 275.16 Cr |
| Operating Expenses | 101.00 Cr | 105.00 Cr | 105.00 Cr | 122.00 Cr | 144.00 Cr | 162.00 Cr | 153.00 Cr | - | 60.25 Cr | 78.97 Cr | 84.17 Cr | 91.55 Cr |
| Operating Income | 155.00 Cr | 170.00 Cr | 179.00 Cr | 208.00 Cr | 172.00 Cr | 73.00 Cr | 88.00 Cr | - | 94.64 Cr | 102.74 Cr | 144.39 Cr | 183.61 Cr |
| EBITDA | 160.00 Cr | 174.00 Cr | 182.00 Cr | 211.00 Cr | 175.00 Cr | 81.00 Cr | 96.00 Cr | - | 137.28 Cr | 158.82 Cr | 206.10 Cr | 252.21 Cr |
| Interest Expense | 1.00 Cr | 0 | 0 | 0 | 0 | 1.00 Cr | 1.00 Cr | - | 1.00 Cr | 1.71 Cr | 2.11 Cr | 2.49 Cr |
| Pretax Income | 197.00 Cr | 178.00 Cr | 212.00 Cr | 233.00 Cr | 202.00 Cr | 104.00 Cr | 119.00 Cr | - | 125.75 Cr | 146.63 Cr | 192.27 Cr | 235.35 Cr |
| Tax Provision | 59.10 Cr | 58.74 Cr | 65.72 Cr | 69.90 Cr | 64.64 Cr | 20.80 Cr | 27.37 Cr | - | 40.29 Cr | 44.07 Cr | 52.26 Cr | 61.66 Cr |
| Net Income | 138.00 Cr | 120.00 Cr | 148.00 Cr | 162.00 Cr | 138.00 Cr | 83.00 Cr | 91.00 Cr | - | 83.53 Cr | 100.52 Cr | 137.24 Cr | 171.18 Cr |
| Diluted EPS | 47.53 | 40.68 | 50.13 | 55.13 | 46.66 | 27.96 | 30.39 | 25.31 | 28.17 | 33.67 | 45.69 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 446.00 Cr | 502.00 Cr | 584.00 Cr | 658.00 Cr | 614.00 Cr | 618.00 Cr | 671.00 Cr | - | 769.62 Cr | 841.76 Cr | 957.74 Cr | 1,104.74 Cr |
| Current Assets | - | - | - | - | - | - | - | - | 601.79 Cr | 674.54 Cr | 692.13 Cr | 677.31 Cr |
| Cash & Equivalents | - | - | - | - | - | - | - | - | 49.42 Cr | 38.29 Cr | 48.82 Cr | 42.60 Cr |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | 20.38 Cr | 22.49 Cr | 32.09 Cr | 35.03 Cr |
| Total Liabilities | - | - | - | - | - | - | - | - | 90.58 Cr | 117.17 Cr | 142.24 Cr | 161.61 Cr |
| Current Liabilities | - | - | - | - | - | - | - | - | 57.81 Cr | 78.68 Cr | 97.80 Cr | 117.68 Cr |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 7.00 Cr | - | 17.48 Cr | 19.55 Cr | 23.77 Cr | 26.18 Cr |
| Total Equity | 359.00 Cr | 408.00 Cr | 520.00 Cr | 596.00 Cr | 550.00 Cr | 533.00 Cr | 588.00 Cr | - | 672.21 Cr | 717.13 Cr | 806.27 Cr | 932.45 Cr |
| Shares Outstanding | - | - | - | - | - | - | - | - | 2.97 Cr | 2.99 Cr | 2.99 Cr | 3.00 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 107.00 Cr | 106.00 Cr | 119.00 Cr | 134.00 Cr | 109.00 Cr | 67.00 Cr | 86.00 Cr | - | 82.24 Cr | 90.88 Cr | 122.95 Cr | 147.57 Cr |
| Investing Cash Flow | 157.00 Cr | -41.00 Cr | -22.00 Cr | -25.00 Cr | 83.00 Cr | 27.00 Cr | -38.00 Cr | - | 12.88 Cr | -39.07 Cr | -58.43 Cr | -94.45 Cr |
| Financing Cash Flow | -276.00 Cr | -66.00 Cr | -96.00 Cr | -99.00 Cr | -195.00 Cr | -107.00 Cr | -43.00 Cr | - | -63.33 Cr | -62.96 Cr | -54.00 Cr | -59.33 Cr |
| Capital Expenditure | -11.00 Cr | -2.00 Cr | -1.00 Cr | -3.00 Cr | -27.00 Cr | -4.00 Cr | -4.00 Cr | - | -11.51 Cr | -9.17 Cr | -14.74 Cr | -8.30 Cr |
| Free Cash Flow | 96.00 Cr | 104.00 Cr | 118.00 Cr | 131.00 Cr | 82.00 Cr | 63.00 Cr | 82.00 Cr | - | 70.74 Cr | 81.71 Cr | 108.22 Cr | 139.27 Cr |
| Net Change in Cash | -12.00 Cr | -1.00 Cr | 1.00 Cr | 11.00 Cr | -4.00 Cr | -13.00 Cr | 5.00 Cr | - | 31.79 Cr | -11.14 Cr | 10.53 Cr | -6.22 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 55.5% | 54.8% | 56.8% | 58.2% |
| Operating Margin % | 59.4% | 60.9% | 62.4% | 62.5% | 53.9% | 29.9% | 35.5% | - | 33.9% | 31.0% | 35.9% | 38.8% |
| Net Margin % | 52.9% | 43.0% | 51.6% | 48.6% | 43.3% | 34.0% | 36.7% | - | 29.9% | 30.3% | 34.1% | 36.2% |
| ROE % | 38.4% | 29.4% | 28.5% | 27.2% | 25.1% | 15.6% | 15.5% | - | 12.4% | 14.0% | 17.0% | 18.4% |
| ROCE % | - | - | - | - | - | - | - | - | 13.3% | 13.5% | 16.8% | 18.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CARERATING
CARERATING: FY26 saw robust revenue and profit growth, with a Rs. 22 per share total dividend recommended - TradingView
<a href="https://news.google.com/rss/articles/CBMikwJBVV95cUxNU1N3bHRJOUZ2SGFyMk5UWlltTEoyb2ZPRTVoSEt6V1hkRnFycmk5eFFON0dINVhUXy03ODBXVldFcGtVSnB3Q21WV1dncGxRb0xpdkNBaW5ZYjBfMkZLM05IN0w0RUVhc0kzSXROR3BYZnhxZFhnVlUzN2xEemdZZXB2R012Y1pLS3h0bl…
CARE Ratings Limited (NSE:CARERATING) Looks Interesting, And It's About To Pay A Dividend - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxQYS11ck5LYmFuVENJRUo3VGJnTlVDbjZWTW1YbWRIeC1mV2gyNXRVaHg0MW1XSlQyWDZEamRLNVg0VmVFXzNyN0pJVXk0bG1KRG5GTWtYSnVVZTNFVkdBMHVyaEhXWVBwUTBsRThtUHJxS2JkZVljUEd2S2xUVmduY2lqYnhrcENlY1kxa0…
CARE Ratings Limited Announces Appointment of Sanjay Agarwal as Chief Risk Officer, Effective August 1, 2026 - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxQLVgxN0hfMXU1R3ZEZkhhOXRJczE4MW5qY1NfMW1CTFNNcnJBS0tXNlBRNUE1TV9YaGVpT2ppcXhCaUpZdEd3NllEV0NETWFwTlFkM0E3ZjdGcUd3cTdvdjRiUkM5NWpwVmVZSHEySDJNR0dNczJlT0FCQ0NadVIyZEpaYXROQmswdlg2ak…
CARE Ratings Ltd. Share Price Today - CARE Ratings Ltd. Stock Price Live NSE/BSE - CNBC TV18
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTFBpTjlwWUt2SnB2Z2JndzBqRzBlWklNTTdWckdGT05PYXJHLWpDUDNrak5RUzg5Z1J1NzN0MmhyY1NWVTFmdlZsdHUtRXkzVXNSUk96Wm1SZDl2YjJDMnl0bDN2RVFUOVZMVDNOVi1TS09vYUtTLUJnODQ3YVI?oc=5" target="_blank">…
CleanMax Secures CARE Rating Upgrade Following Strong Financial And Renewable Energy Portfolio Growth - SolarQuarter
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNajBxTFlJZVNVM096Z3Izb2xVSEc5NTR6N1pwNXQxOUtSU0hMVE45UFFjbWNublpLQkRpek5YeDVIcC01cFIwWDJSQW9SdkY0QVVFcWdRNnQySWtTTG9PYkVlOTV2SUVzTzhabFJYZ1duOFJXZTE4TDFZdi1lc2JyZkFhb3l1OXBXTGk5OW…
Council's social care rating regraded to 'good' - BBC
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1HV0RWd1JMSk5oSmd4WDl4b1ZUTmRkTWNuY18xUnpxMTI5bk43M0JhOTM0NnlWbGszaEV6eTRJWjRUU0ItQmNUYU13Rjl4T1Q3c1VMbUZlT2dNazdB?oc=5" target="_blank">Council's social care rating regraded to 'g…
CARERATING — Frequently Asked Questions
What is the current share price of CARERATING?
As of 2026-07-15 09:52 IST, CARERATING trades at ₹1,678.70 on NSE. Its 52-week range is ₹1,400.72 to ₹1,825.42.
What is the market capitalisation of CARERATING?
CARERATING has a market capitalisation of ₹5,043.99 Cr on NSE.
What is the P/E ratio of CARERATING?
CARERATING trades at a trailing price-to-earnings (P/E) ratio of 36.74. Its price-to-book (P/B) ratio is 5.40.
What is the return on equity (ROE) of CARERATING?
CARERATING has a return on equity (ROE) of 18.36%. Its return on capital employed (ROCE) is 18.60%.
Is CARERATING a good stock to buy?
This page provides a data-driven analysis of CARERATING, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.